534 related articles for article (PubMed ID: 19880712)
1. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.
Thauvin-Robinet C; Munck A; Huet F; Génin E; Bellis G; Gautier E; Audrézet MP; Férec C; Lalau G; Georges MD; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Costa C; Medina R; Leclerc J; Hubert D; Nové-Josserand R; Sermet-Gaudelus I; Rault G; Flori J; Leroy S; Wizla N; Bellon G; Haloun A; Perez-Martin S; d'Acremont G; Corvol H; Clément A; Houssin E; Binquet C; Bonithon-Kopp C; Alberti-Boulmé C; Morris MA; Faivre L; Goossens M; Roussey M; ; Girodon E
J Med Genet; 2009 Nov; 46(11):752-8. PubMed ID: 19880712
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotype of cystic fibrosis patients with the G551D mutation.
Comer DM; Ennis M; McDowell C; Beattie D; Rendall J; Hall V; Elborn JS
QJM; 2009 Nov; 102(11):793-8. PubMed ID: 19734299
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
[TBL] [Abstract][Full Text] [Related]
5. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
6. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
8. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina.
Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS
Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248
[TBL] [Abstract][Full Text] [Related]
9. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
Schwartz M
Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
[TBL] [Abstract][Full Text] [Related]
10. Carrier frequency of F508del mutation of cystic fibrosis in Indian population.
Kapoor V; Shastri SS; Kabra M; Kabra SK; Ramachandran V; Arora S; Balakrishnan P; Deorari AK; Paul VK
J Cyst Fibros; 2006 Jan; 5(1):43-6. PubMed ID: 16311077
[TBL] [Abstract][Full Text] [Related]
11. High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France.
des Georges M; Guittard C; Altiéri JP; Templin C; Sarles J; Sarda P; Claustres M
J Cyst Fibros; 2004 Dec; 3(4):265-72. PubMed ID: 15698946
[TBL] [Abstract][Full Text] [Related]
12. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.
Duguépéroux I; De Braekeleer M;
J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
Mussaffi H; Prais D; Mei-Zahav M; Blau H
Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
[TBL] [Abstract][Full Text] [Related]
15. CFTR genotypes in patients with normal or borderline sweat chloride levels.
Feldmann D; Couderc R; Audrezet MP; Ferec C; Bienvenu T; Desgeorges M; Claustres M; Mittre H; Blayau M; Bozon D; Malinge MC; Monnier N; Bonnefont JP; Iron A; Bieth E; Dumur V; Clavel C; Cazeneuve C; Girodon E
Hum Mutat; 2003 Oct; 22(4):340. PubMed ID: 12955726
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France.
Claustres M; Guittard C; Bozon D; Chevalier F; Verlingue C; Ferec C; Girodon E; Cazeneuve C; Bienvenu T; Lalau G; Dumur V; Feldmann D; Bieth E; Blayau M; Clavel C; Creveaux I; Malinge MC; Monnier N; Malzac P; Mittre H; Chomel JC; Bonnefont JP; Iron A; Chery M; Georges MD
Hum Mutat; 2000; 16(2):143-56. PubMed ID: 10923036
[TBL] [Abstract][Full Text] [Related]
17. Penetrance is a critical parameter for assessing the disease liability of CFTR variants.
Boussaroque A; Audrézet MP; Raynal C; Sermet-Gaudelus I; Bienvenu T; Férec C; Bergougnoux A; Lopez M; Scotet V; Munck A; Girodon E
J Cyst Fibros; 2020 Nov; 19(6):949-954. PubMed ID: 32327388
[TBL] [Abstract][Full Text] [Related]
18. CFTR mutations in patients from Colombia: implications for local and regional molecular diagnosis programs.
Keyeux G; Rodas C; Bienvenu T; Garavito P; Vidaud D; Sanchez D; Kaplan JC; Aristizábal G
Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938099
[TBL] [Abstract][Full Text] [Related]
19. CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders.
Thauvin-Robinet C; Munck A; Huet F; de Becdelièvre A; Jimenez C; Lalau G; Gautier E; Rollet J; Flori J; Nové-Josserand R; Soufir JC; Haloun A; Hubert D; Houssin E; Bellis G; Rault G; David A; Janny L; Chiron R; Rives N; Hairion D; Collignon P; Valeri A; Karsenty G; Rossi A; Audrézet MP; Férec C; Leclerc J; Georges Md; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Cheillan D; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Izard V; Steffann J; Viville S; Costa C; Drouineaud V; Fauque P; Binquet C; Bonithon-Kopp C; Morris MA; Faivre L; Goossens M; Roussey M; Girodon E;
J Med Genet; 2013 Apr; 50(4):220-7. PubMed ID: 23378603
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.
Massie RJ; Wilcken B; Van Asperen P; Dorney S; Gruca M; Wiley V; Gaskin K
J Pediatr; 2000 Aug; 137(2):214-20. PubMed ID: 10931414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
